Could a traditional chinese herbal granule boost stroke recovery?

NCT ID NCT07163702

Not yet recruiting Disease control Sponsor: Dongzhimen Hospital, Beijing Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests a traditional Chinese herbal medicine called Xinglou Chengqi Granule for people who recently had a stroke. Researchers want to find the best dose and see if it helps improve recovery. Sixty adults aged 18-70 with moderate stroke symptoms will receive either a high or low dose of the granules plus standard care. The main goal is to measure changes in stroke-related disability after 14 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Xinglou Chengqi Granule (herbal granules)
What this could lead to: If successful, this could point toward a new herbal treatment option to improve recovery after a stroke.
What could go wrong: This is an early phase 2a trial with only 60 participants, so results are preliminary. The herbal granules may not prove more effective than standard care, and side effects are not yet well understood.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE

Contacts and locations

Locations

Dongzhimen Hospital, Beijing University of Chinese Medicine

Richmond, British Columbia, V7E 6J1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.